ONE Bio Corp
ONE Bio Corp., an agritech company, together with its subsidiaries, utilizes green process manufacturing to produce raw chemicals and herbal extracts, natural supplements, and organic products. The company operates through two business units, Chemical and Herbal Extracts (CHE) and Organic Products (OP). The CHE business unit engages in the development, manufacture, and commercialization of bio-ec… Read more
ONE Bio Corp (ONBI) - Total Assets
Latest total assets as of September 2011: $82.86 Million USD
Based on the latest financial reports, ONE Bio Corp (ONBI) holds total assets worth $82.86 Million USD as of September 2011.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
ONE Bio Corp - Total Assets Trend (2005–2010)
This chart illustrates how ONE Bio Corp’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
ONE Bio Corp - Asset Composition Analysis
Current Asset Composition (December 2010)
ONE Bio Corp's total assets of $82.86 Million consist of 56.7% current assets and 43.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 15.2% |
| Accounts Receivable | $20.05 Million | 28.6% |
| Inventory | $4.51 Million | 6.4% |
| Property, Plant & Equipment | $8.87 Million | 12.7% |
| Intangible Assets | $2.30 Million | 3.3% |
| Goodwill | $1.60 Million | 2.3% |
Asset Composition Trend (2005–2010)
This chart illustrates how ONE Bio Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: ONE Bio Corp's current assets represent 56.7% of total assets in 2010, an increase from 24.5% in 2005.
- Cash Position: Cash and equivalents constituted 15.2% of total assets in 2010, down from 23.1% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, an increase from 0.0% in 2005.
- Asset Diversification: The largest asset category is accounts receivable at 28.6% of total assets.
ONE Bio Corp Competitors by Total Assets
Key competitors of ONE Bio Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
ONE Bio Corp - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - ONE Bio Corp generates 0.75x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, ONE Bio Corp generates $ 12.38 in net profit.
ONE Bio Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.57 | 1.34 | 1.18 |
| Quick Ratio | 1.29 | 1.14 | 1.18 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $18.15 Million | $ 9.34 Million | $ 10.29K |
ONE Bio Corp - Advanced Valuation Insights
This section examines the relationship between ONE Bio Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.01 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 28.3% |
| Total Assets | $70.09 Million |
| Market Capitalization | $27.49 USD |
Valuation Analysis
Below Book Valuation: The market values ONE Bio Corp's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: ONE Bio Corp's assets grew by 28.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for ONE Bio Corp (2005–2010)
The table below shows the annual total assets of ONE Bio Corp from 2005 to 2010.
| Year | Total Assets | Change |
|---|---|---|
| 2010-12-31 | $70.09 Million | +28.28% |
| 2009-12-31 | $54.63 Million | +107218.79% |
| 2008-12-31 | $50.91K | -73.84% |
| 2007-12-31 | $194.57K | +58.85% |
| 2006-12-31 | $122.49K | +44.45% |
| 2005-12-31 | $84.79K | -- |